AIM RX 3PL, LLC — Clindamycin Importer Profile
Pharmaceutical Importer · #7 buyer for Clindamycin · $2.4M import value · 80 shipments · UNITED STATES · DGFT Verified
AIM RX 3PL, LLC is the #7 importer of Clindamycin from India with $2.4M in import value and 80 verified shipments. AIM RX 3PL, LLC holds a 3.6% market share in Clindamycin imports based in UNITED STATES. The company sources from 1 verified supplier across 38 formulations shipped to 1 country. Overall, AIM RX 3PL, LLC imports 4 pharmaceutical products worth $13.4M across 4 therapeutic categories.
AIM RX 3PL, LLC — Clindamycin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Clindamycin to AIM RX 3PL, LLC?
Verified from 80 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| ENCUBE ETHICALS PRIVATE LIMITED | $2.4M | 80 | 100.0% |
AIM RX 3PL, LLC sources Clindamycin from 1 verified Indian supplier based on 80 customs records. The primary supplier is ENCUBE ETHICALS PRIVATE LIMITED accounting for 100.0% of imports.
How Does AIM RX 3PL, LLC Compare to Nearest Clindamycin Importers?
Buyers ranked immediately above and below #7 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | CARDINAL HEALTH | UNITED STATES | $4.7M | 94 | $50.0K |
| 7 | AIM RX 3PL, LLC ★ | UNITED STATES | $3.3M | 73 | $45.1K |
| 8 | EVERSANA LIFE SCIENCE SERVICES | UNITED STATES | $3.1M | 84 | $36.4K |
| 3 | IPD, SC, USA | UNITED STATES | $3.0M | 61 | $50.0K |
AIM RX 3PL, LLC ranks #7 among 1,029 Clindamycin importers from India. Average shipment value of $45.1K compared to the market average of $30.8K. The closest competitors by value are CARDINAL HEALTH and EVERSANA LIFE SCIENCE SERVICES.
Where Does AIM RX 3PL, LLC Import Clindamycin To?
Destination countries from 80 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $2.4M | 80 | 100.0% |
AIM RX 3PL, LLC imports Clindamycin to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $2.4M.
What Clindamycin Formulations Does AIM RX 3PL, LLC Import?
| Formulation | Value | Shipments |
|---|---|---|
| CLINDAMYCIN PHOSPHATE TOPICAL SOLUTION U | $362.7K | 12 |
| CLINDAMYCIN PHOSPHATE TOP. LOT.1% 60ML ( | $336.6K | 9 |
| CLINDAMYCIN (PHOSPHATE) GEL 1% 30GM (CLI | $156.8K | 4 |
| CLINDAMYCIN (PHOSPHATE) GEL 1% 60GM (CLI | $136.7K | 4 |
| PRODUCT CODE : FG0002 CLINDAMYCIN PHOSPHATE TOPICAL SOLUTION USP,1% 60ML B.NO.4BH22 TO 4BH25 MFG DATE MAR 2024 EXP DATE | $111.8K | 6 |
| CLINDAMYCIN PHOSPHATE TOPICAL LOTION, 1%,60ML B.No.4CW80 AND 4CW82 TO 4CW84 MFGDate MAY 2024 EXP Date APR 2026 | $100.0K | 2 |
| CLINDAMYCIN(PHOSPHATE)GEL 60 GM BATCH NO.4BG04,4BG06A,4BG05 MFG DT.FEB 2024 EXPDT. JAN 2026 | $91.6K | 3 |
| CLINDAMYCIN PHOSPHATE GEL 30 GM B.No.4BG21 MFG Date JUN 2024 EXP Date MAY 2026 | $77.9K | 2 |
| CLINDAMYCIN PHOSPHATE TOP. LOT.1% 60ML, | $50.0K | 1 |
| CLINDAMYCIN PHOSPHATE TOPICAL SOLUTION USP,1% 60ML B.No.5BH10 TO 5BH13 MFG DateJAN 2025 EXP Date DEC 2027 | $50.0K | 1 |
AIM RX 3PL, LLC imports 38 distinct Clindamycin formulations from India. The top formulation is CLINDAMYCIN PHOSPHATE TOPICAL SOLUTION U with 12 shipments worth $362.7K.
Regulatory Requirements: Importing Clindamycin into United States
What AIM RX 3PL, LLC and other importers must comply with to import Clindamycin from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Clindamycin
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Clindamycin from India and How Much Does AIM RX 3PL, LLC Import?
India exported $31.6M worth of Clindamycin through 7,242 shipments from 527 suppliers to 144 countries, serving 1,029 buyers globally. AIM RX 3PL, LLC imports $2.4M of this total, accounting for 3.6% of India's Clindamycin exports with 80 shipments from UNITED STATES. This is verified from 80 customs shipment records covering 38 distinct formulations.
What Is the Average Order Value for AIM RX 3PL, LLC's Clindamycin Imports?
AIM RX 3PL, LLC's average Clindamycin order value is $30.4K per consignment, based on 80 shipments totaling $2.4M. AIM RX 3PL, LLC is based in UNITED STATES and ranks #7 among all Clindamycin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Clindamycin to AIM RX 3PL, LLC?
AIM RX 3PL, LLC sources Clindamycin from 1 verified Indian supplier: ENCUBE ETHICALS PRIVATE LIMITED ($2.4M, 100.0%). This is based on 80 customs records.
How Does AIM RX 3PL, LLC Compare to Other Clindamycin Importers?
AIM RX 3PL, LLC ranks #7 among 1,029 Clindamycin importers from India with a 3.6% market share. The top 3 importers are CARDINAL HEALTH ($4.7M), AIM RX 3PL, LLC ($3.3M), EVERSANA LIFE SCIENCE SERVICES ($3.1M). AIM RX 3PL, LLC processed 80 shipments from UNITED STATES.
About AIM RX 3PL, LLC
AIM RX 3PL, LLC imports 4 products worth $13.4M. Beyond Clindamycin, top products include Diclofenac, Sodium, Ketoconazole. View the complete AIM RX 3PL, LLC profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Clindamycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Clindamycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: AIM RX 3PL, LLC matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as AIM RX 3PL, LLC's capped import value divided by total capped export value for Clindamycin across all Indian exporters.
- 5.Verified Records: This page is backed by 80 individual customs records matching AIM RX 3PL, LLC importing Clindamycin, covering 38 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 144+ countries, 1,029+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Clindamycin Import Data for AIM RX 3PL, LLC
Access order-level details, pricing data, supplier connections, and competitive analysis for AIM RX 3PL, LLC's Clindamycin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
AIM RX 3PL, LLC
Full Company Profile →
4 products · $13.4M total trade · 4 categories
AIM RX 3PL, LLC × Clindamycin
Verified from customs records
Company Overview
Top Products by AIM RX 3PL, LLC
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for AIM RX 3PL, LLC.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Clindamycin. For current order-level data, contact TransData Nexus.